X

Ortin Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 247 users | BSE: 539287 | NSE: ORTINLABSS |
Pharmaceuticals & Drugs
Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 12.38%11.32%9.93%9.54%8.01%7.31%5.81%7.32%8.21%3.87%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 6585.874.867.160.462.966.879.7168197
Y-o-Y Gr. Rt.-32%-12.8%-10.3%-10%4.2%6.1%19.4%110.5%17.7%
Adjusted EPS (Rs.) 3.410.790.640.70.530.480.240.330.75-0.32
Y-o-Y Gr. Rt.--76.8%-19%9.4%-24.3%-9.4%-50%37.5%127.3%-142.7%
Book Value per Share (Rs.) 15.8911.9112.2512.9613.2513.7413.8114.2114.8114.06
Adjusted Net Profit 1.61.31.11.20.90.80.40.61.3-0.6
Net Op. Cash Flow (Rs. Cr.) 1.60.3-1.7-1.8-1.40.51.91.66.56.2
Debt to Cash Flow from Ops 7.1344.48-10.82-10.61-15.2440.378.9311.132.993.14
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Ortin Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 13.1%26.7%43.5%17.7%
Adjusted EPS -176.9%-190.4%-210.1%-142.7%
Book Value per Share -1.41.20.6-5.1
Share Price 3.1% 11.5% 15.8% 277%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 11.966.75.295.534.063.531.772.395.19-2.23
Operating Profit Margin (%) 6.048.218.799.0710.49.368.026.943.722.89
Net Profit Margin (%) 2.471.571.451.761.491.280.620.710.76-0.28
Debt to Equity 1.50.650.860.850.930.90.740.720.780.82
Working Capital Days 107181239239259235223205144159
Cash Conversion Cycle 24102150851171271186151
Entity Percentage Holding
Promoters 34.84%
Non-Institutions 65.16%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Ortin Laboratories Ltd's performance infers:

Ortin Laboratories Ltd earnings have declined by -190.4%, whereas share price has appreciated 11.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Ortin Laboratories Ltd share prices over the last 10 years. Here is what we found out:

Ortin Laboratories Ltd share price has appreciated 1.4% annually over the past ten years.

Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP

Ortin Laboratories established in the year 1986  was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Quality is the hallmark of Ortin. At every stage of production from raw material to finished products, highest standard of quality is ensured with the help of most modern equipment and experienced personnel.This unflinching perseverance towards quality has helped the company to earn enormous goodwill & trust, both from medical profession and pharmaceutical trade.

Being in partnership with the world means respecting its resources without compromise and so at Ortin, continuous process evaluation and monitoring waste recoveries ensure that the focus is maintained. Specialized facilities have helped us to earn a reputation for the expert handling of hazardous materials in the form of reactants and products. Teams from the ministry of health regularly inspect the company's plant. Every care is taken for treatment of solid wasters, discharged liquids and atmospheric releases.

Ortin is contemplating an entry into the OTC segment as part of its long term growth strategy. It is channeling its efforts towards building an overseas marketing network in order to enhance exports to third world countries. Ortin proposes to be certified as a WHO GMP Unit and to launch innovative Biotechnology products in Orthopedic and Dental Segments. The success behind them is only the Reliance which they carry for their Quality from the people all over the country. Their motto, right from their inception has been towards Quality and they still maintain them and continue to do so in future.

Products manufactured by the company include:

  • Capsules
  • Syrups / Dry syrups
  • Powders
  • Second Division Products
  • Generic Products

Achievements/ recognition :

  • Ortin has been certified as an ISO 9001: 2000 company by the internationally recognized Quality Management Certification Body, the National Quality Assurance, UK in pursuance of its focus towards Quality with its Policy to enhance customer satisfaction by providing Quality Pharmaceutical Formulations at optimum cost and maintain profitability through continual improvement of Quality Management Sytems and cGMP.
  • Ortin is honored as a registered Supplier of Drugs & Medicines with the most reputed Central, State & Quasi-Government Organizations & Institutions of our Country such as the Railways, Health Ministry, Defence, Posts & Telegraph, Electricity Hospitals, Transport Organizations, Research Institutions such as JIPMER, IICT etc.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback